GlaxoSmithKline

GSK ready to 'walk the talk' in outbreak preparedness with new R&D hub

With $496M CNS sale, Novartis joins the herd of pharmas casting off tired meds

FiercePharmaAsia: GSK’s new China head, repercussions from Japan’s Opdivo price cut, Takeda’s €100M dengue vax plant, Sun Pharma and others